What causes Hashimoto's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Hashimoto's Thyroiditis

Hashimoto's thyroiditis is primarily caused by a complex interplay of genetic susceptibility, environmental triggers, and autoimmune mechanisms that lead to T-cell and B-cell mediated destruction of the thyroid gland. 1

Genetic Factors

  • Genetic predisposition plays a crucial role in the development of Hashimoto's thyroiditis:
    • Strong HLA associations, particularly with HLA-DR/DQ genes that can be either predisposing or protective 2
    • Family history is significant, with up to 42% of patients reporting family history of the condition 1
    • X-chromosome inactivation patterns contribute to the female predominance (7-10 times more common in women than men) 3
    • Genetic polymorphisms of vitamin D receptor (VDR), vitamin D binding protein (DBP), and 1α-hydroxylase (CYP1α) may predispose to Hashimoto's development 4

Autoimmune Mechanisms

  • Autoimmune destruction of thyroid cells occurs through:
    • Cellular immunity: T-cell inflammatory infiltration of the thyroid gland 5
    • Humoral immunity: Production of thyroid-specific autoantibodies 1
      • Anti-thyroid peroxidase antibodies (TPO-Ab)
      • Anti-thyroglobulin antibodies (TG-Ab)
    • Abnormal expression of MHC class II surface HLA-DR antigens on thyrocytes 4
    • Production of inflammatory cytokines (especially IFN-γ) by T helper (Th1) lymphocytes 4

Environmental Triggers

Several environmental factors have been implicated in triggering Hashimoto's thyroiditis:

  • Iodine intake: Excessive iodine consumption may trigger autoimmune thyroiditis in genetically susceptible individuals 2, 6
  • Infections: Various bacterial and viral infections may serve as triggers 6
  • Vitamin D deficiency: Significantly associated with Hashimoto's thyroiditis development due to vitamin D's immunomodulatory role 4
  • Stress: Psychological stress may contribute to immune dysregulation 6
  • Microbiome composition: Alterations in gut microbiota may influence autoimmune processes 3

Associated Conditions

Hashimoto's thyroiditis frequently coexists with other autoimmune disorders:

  • Other autoimmune thyroid diseases (10-23% of patients) 1
  • Systemic lupus erythematosus (2.8-3% of patients) 1
  • Sjögren syndrome (2.8-7% of patients) 1
  • Rheumatoid arthritis (2-4% of patients) 1
  • Inflammatory bowel disease (2-11.4% of patients) 1
  • Addison's disease, vitiligo, celiac sprue, autoimmune hepatitis, myasthenia gravis, and pernicious anemia 2

Pathophysiological Process

The pathogenesis involves a sequential process:

  1. Initial genetic susceptibility and environmental trigger exposure
  2. Loss of self-tolerance to thyroid antigens
  3. Infiltration of thyroid by lymphocytes and formation of lymphoid follicles with germinal centers 5
  4. Production of thyroid-specific autoantibodies
  5. Progressive destruction of thyrocytes leading to parenchymal atrophy 5
  6. Development of hypothyroidism as the gland's ability to produce hormones diminishes

Clinical Implications

The understanding of these causal factors has important clinical implications:

  • Screening for vitamin D deficiency and supplementation may be beneficial for patients with Hashimoto's thyroiditis 4
  • Monitoring for other autoimmune conditions is warranted in patients with Hashimoto's thyroiditis
  • TPO antibody status may influence treatment outcomes and should be tested alongside TSH and Free T4 1
  • Patients with Hashimoto's thyroiditis have a 1.6 times higher risk of papillary thyroid cancer and 60 times higher risk of thyroid lymphoma compared to the general population 3

Understanding these multifactorial causes helps guide appropriate monitoring and management of patients with Hashimoto's thyroiditis to improve morbidity, mortality, and quality of life outcomes.

References

Guideline

Thyroid Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.